William R. Polkinghorn

Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers

William R. Polkinghorn, Joel S. Parker, Man X. Lee et al. · Cancer Discovery · 2013 · 567 citations · Full text

Medicine, Cancer Biology, Oncology +17

The Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam Radiotherapy

Zachary S. Zumsteg, Daniel E. Spratt, Paul B. Romesser et al. · European Urology · 2014 · 199 citations · Full text

Medicine, Oncology, Radiation Oncology +16

High-Risk Medulloblastoma: A Pediatric Oncology Group Randomized Trial of Chemotherapy Before or After Radiation Therapy (POG 9031)

Nancy J. Tarbell, Henry S. Friedman, William R. Polkinghorn et al. · Journal of Clinical Oncology · 2013 · 166 citations · Full text

Medicine, Oncology, Pediatrics +17

Comparison of high‐dose (86.4  <scp>G</scp> y) <scp>IMRT</scp> vs combined brachytherapy plus <scp>IMRT</scp> for intermediate‐risk prostate cancer

Daniel E. Spratt, Zachary S. Zumsteg, Pirus Ghadjar et al. · British Journal of Urology · 2013 · 140 citations

Medicine, Oncology, Radiation Oncology +13

Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation

Daniel E. Spratt, Michael J. Evans, Brian J. Davis et al. · Cancer Research · 2015 · 129 citations · Full text

Medicine, Oncology, Radiation Oncology +17